Eli Lilly Says It Will Raise European Prices of its Medicines as Trump Pushes for U.S. Price Cuts

The White House’s effort to lower drug prices in the U.S. is bringing higher drug prices to Europe. The Indiana-based drugmaker Eli Lilly said on Thursday that it is raising the list prices of its drugs overseas. Lilly said that “the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the US.”

Continue Reading

View Comments